Aquestive Therapeutics to present Anaphylm clinical data at 2026 ACAAI meeting
AQST•Aquestive Therapeutics will present research on investigational Anaphylm sublingual film at the ACAAI annual meeting in Phoenix, November 12-16, 2026.
1. Planned presentations
Oral presentations on November 14 will examine the drug’s absorption and effects during allergic reactions, including use on top of the tongue. Posters on November 13 will address epinephrine film’s effects at low exposure levels and healthcare providers’ perspectives on anaphylaxis treatment needs.
